Last viewed:
STIM
Prices are updated after-hours
STIM
|
$3.865
3.34%
3.23%
41K
|
Health Technology
(0.0% 1d)
(-18.0% 1m)
(73.1% 1y)
(0.0% 2d)
(3.2% 3d)
(0.8% 7d)
(-24.56%
volume)
Earnings Calendar: 2023-11-07
Market Cap: $ 115,851,895
http://www.neuronetics.com
Sec
Filling
|
Patents
| 235 employees
(US) Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.
education
treatment
add to watch list
Paper trade
email alert is off
Press-releases
Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
Published: 2024-04-23
(Crawled : 20:00)
- globenewswire.com
STIM
|
$3.865
3.34%
3.23%
41K
|
Health Technology
| Email alert
Add to watchlist
first
conference
report
financial
results
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Published: 2024-04-10
(Crawled : 12:30)
- globenewswire.com
STIM
|
$3.865
3.34%
3.23%
41K
|
Health Technology
| -8.75%
| O: 1.18%
H: 4.28%
C: 1.17%
publication
treatment
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is VitalLack of early symptom improvement is not predictive of final responder status
Published: 2024-04-10
(Crawled : 22:00)
- biospace.com/
STIM
|
$3.865
3.34%
3.23%
41K
|
Health Technology
| -8.75%
| O: 1.18%
H: 4.28%
C: 1.17%
publication
treatment
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-27
(Crawled : 21:00)
- globenewswire.com
STIM
|
$3.865
3.34%
3.23%
41K
|
Health Technology
| -19.58%
| O: 0.0%
H: 2.29%
C: -0.83%
nasdaq
grant
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
Published: 2024-03-25
(Crawled : 12:30)
- globenewswire.com
STIM
|
$3.865
3.34%
3.23%
41K
|
Health Technology
| -8.75%
| O: 13.48%
H: 3.96%
C: -1.88%
neurostar
fda
depression
treatment
clearance
advanced
therapy
GREENBROOK ANNOUNCES QUOTATION ON OTCQB
Published: 2024-03-21
(Crawled : 21:00)
- prnewswire.com
STIM
|
$3.865
3.34%
3.23%
41K
|
Health Technology
| -10.02%
| O: 0.0%
H: 1.77%
C: -1.4%
otcqb
Electroceuticals Market / Bioelectric Medicine Market Worth $33.6 billion | MarketsandMarkets™
Published: 2024-03-13
(Crawled : 14:30)
- prnewswire.com
NVRO
|
$12.79
4.24%
0.0%
410K
|
Health Technology
| -12.76%
| O: -0.55%
H: 1.99%
C: -1.65%
MDT
|
$81.29
0.89%
0.0%
5.2M
|
Health Technology
| -5.19%
| O: 0.31%
H: 0.4%
C: -1.08%
BSX
|
$68.99
1.43%
0.19%
9.1M
|
Health Technology
| 2.22%
| O: 0.16%
H: 0.0%
C: -2.31%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
| -10.48%
| O: 0.41%
H: 0.0%
C: 0.0%
STIM
|
$3.865
3.34%
3.23%
41K
|
Health Technology
| -10.44%
| O: -0.7%
H: 3.5%
C: -1.4%
LIVN
|
$55.01
1.85%
1.82%
640K
|
Health Technology
| 5.85%
| O: -0.6%
H: 2.36%
C: 1.18%
ECOR
|
$5.9
4.98%
4.75%
7.3K
|
Health Technology
| -8.86%
| O: -0.16%
H: 4.03%
C: 4.03%
AXNX
|
$66.54
-0.45%
-0.45%
1.1M
|
Health Technology
| -1.74%
| O: 0.0%
H: 0.37%
C: 0.28%
market
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
Published: 2024-03-07
(Crawled : 13:30)
- globenewswire.com
STIM
|
$3.865
3.34%
3.23%
41K
|
Health Technology
| -3.98%
| O: 0.0%
H: 4.48%
C: -1.24%
partnership
care
network
Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
Published: 2024-03-05
(Crawled : 12:30)
- globenewswire.com
STIM
|
$3.865
3.34%
3.23%
41K
|
Health Technology
| 38.35%
| O: 7.53%
H: 9.67%
C: 7.33%
year
financial
results
GREENBROOK APPOINTS CHIEF OPERATING OFFICER
Published: 2024-03-04
(Crawled : 22:00)
- prnewswire.com
STIM
|
$3.865
3.34%
3.23%
41K
|
Health Technology
| 38.35%
| O: 7.53%
H: 9.67%
C: 7.33%
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount